| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/05/2002 | EP1210100A1 Method of treating traumatic brain and spinal cord injuries and other neurogenic conditions using non-steroidal anti-inflammatory drugs and naturally occurring conotoxins |
| 06/05/2002 | EP1210096A1 Health food useful for preventing liver and biliary dysfunctions containing an alkanoyl l-carnitine and silybum marianum extract |
| 06/05/2002 | EP1210093A1 Degradable polymers |
| 06/05/2002 | EP1210091A1 Heartburn treatment |
| 06/05/2002 | EP1210090A2 Use of chemical chelators as reversal agents for drug-induced neuromuscular block |
| 06/05/2002 | EP1210088A1 2-amino-benzoxazinones for the treatment of herpes simplex virus |
| 06/05/2002 | EP1210087A2 Pentoxifylline, pioglitazone and metformin are inhibitors of formation of advanced glycation endproducts (age's) |
| 06/05/2002 | EP1210086A1 Promotion of wound healing |
| 06/05/2002 | EP1210085A2 Pharmaceutical solutions of levosimendan |
| 06/05/2002 | EP1210084A1 Pyridomorphinans, thienomoprhinans and use thereof |
| 06/05/2002 | EP1210083A2 Methods for the treatment of mental and vascular disorders |
| 06/05/2002 | EP1210082A2 Long chain n-alkyl compounds and oxa-derivatives thereof and use as antiviral compositions |
| 06/05/2002 | EP1210081A2 Combination of active agents, said combination containing clonidine |
| 06/05/2002 | EP1210080A2 Use of monoamine oxidase inhibitors for the manufacture of drugs intended for the treatment of obesity |
| 06/05/2002 | EP1210079A2 A pharmaceutical delivery system for vitamin c and vitamin e and use of a combination of vitamin c and e for preventing or treating conditions involving oxidative stress |
| 06/05/2002 | EP1210078A1 Improved topical medicaments and methods for photodynamic treatment of disease |
| 06/05/2002 | EP1210077A1 Compositions and systems for the treatment of hyperpigmentation |
| 06/05/2002 | EP1210076A2 Drug therapy of the restless leg syndrome |
| 06/05/2002 | EP1210075A1 Compositions and methods for modification of skin lipid content |
| 06/05/2002 | EP1210074A2 Compositions including modafinil for treatment of eating disorders and for appetite stimulation |
| 06/05/2002 | EP1210073A1 Sunscreen agent for oral administration |
| 06/05/2002 | EP1210072A1 Plastic films, especially for use in a dermal or transdermal therapeutic system |
| 06/05/2002 | EP1210070A1 Agent for stimulating bowel function and method for producing the same |
| 06/05/2002 | EP1210069A2 Large porous particles by spray-drying |
| 06/05/2002 | EP1210067A2 Modulation of release from dry powder formulations |
| 06/05/2002 | EP1210066A1 Microencapsulated and controlled-release formulations of isoflavone from enriched fractions of soy and other plants |
| 06/05/2002 | EP1210065A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 06/05/2002 | EP1210063A1 Compositions and methods for enhanced absorption of hydrophilic therapeutic agents |
| 06/05/2002 | EP1210040A2 Apparatus and method for anesthetizing the cervical region of a female |
| 06/05/2002 | EP1209988A1 Cross-linked agent for generation of a long-lasting satiety effect and method for the production of the said |
| 06/05/2002 | EP1209987A1 Composition for preventing iodine deficiency |
| 06/05/2002 | EP1209986A1 Metal-containing compositions, preparations and uses |
| 06/05/2002 | EP1137438B1 Formulation with an improved therapeutic range, containing nucleotide synthesis inhibitors |
| 06/05/2002 | EP1121117B1 Oxaliplatinum preparation packaging |
| 06/05/2002 | EP1121112B1 Stable formoterol concentrate |
| 06/05/2002 | EP1109817B1 Phosphohalohydrins, method for making same and uses |
| 06/05/2002 | EP1105379B1 Water soluble analogs and prodrugs of paclitaxel |
| 06/05/2002 | EP1061909B1 Keto acid salts and amine derivatives, and their use for preparing medicines |
| 06/05/2002 | EP1039895B1 Use of 3-benzoyl-phenylacetic acids, esters, or amides for treatment of glc1a glaucoma |
| 06/05/2002 | EP1023273B1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5ht1a receptors |
| 06/05/2002 | EP1021191B1 Tightening and/or reducing the size of body parts containing fat cells |
| 06/05/2002 | EP1021187A4 Methods and compositions for protecting against cardiac ischemia by administering adenosine a 2a? receptor antagonists |
| 06/05/2002 | EP0975592B1 Benzyloxy prodigiosine compounds |
| 06/05/2002 | EP0971920B1 Compounds for inhibition of gastric acid secretion |
| 06/05/2002 | EP0970090B1 Substituted 4-arylmethylene-2-imino-2,3-dihydrothiazoles and derivatives and their pharmaceutical use |
| 06/05/2002 | EP0966430B1 Anti-inflammatory compounds |
| 06/05/2002 | EP0946139B1 Pharmaceutical formulation |
| 06/05/2002 | EP0944628B1 Hetero-biaryl-pyridoquinazolinone derivatives as anti-cancer agents |
| 06/05/2002 | EP0937054B1 4-(1-piperazinyl)benzoic acid derivatives, process for preparing them and their therapeutic applications |
| 06/05/2002 | EP0934319B1 1H-PYRIDO[3,4-b]INDOLE-4-CARBOXAMIDE DERIVATIVES, PREPARATION AND APPLICATION THEREOF IN THERAPEUTICS |
| 06/05/2002 | EP0930888B1 Pharmaceutical and cosmetic antiacne formulations containing plant extracts (krameria triandra or mesua ferrea) |
| 06/05/2002 | EP0923551B1 4-aminoethoxy indolone derivatives |
| 06/05/2002 | EP0923539B1 Compounds with growth hormone releasing properties |
| 06/05/2002 | EP0909268B1 Method for preparing substituted anthraquinone and application to the preparation of rheins |
| 06/05/2002 | EP0894008B1 Method of producing immunogenic products and vaccines |
| 06/05/2002 | EP0888337B1 Piperidone tachykinin antagonists |
| 06/05/2002 | EP0883599B1 Aminotetralin derivatives and compositions and method of use thereof |
| 06/05/2002 | EP0879057B1 Granules from triazines |
| 06/05/2002 | EP0876336B1 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 06/05/2002 | EP0874853B1 Process for preparation of cefdinir |
| 06/05/2002 | EP0871443B1 Advanced glycation end-product intermediaries and post-amadori inhibition |
| 06/05/2002 | EP0858338B1 Use of levo-enantiomers of medetomidine derivatives |
| 06/05/2002 | EP0851855B1 Acylated derivatives of melatonin and its analogues, useful as medicaments |
| 06/05/2002 | EP0840609B1 Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents |
| 06/05/2002 | EP0815134B1 Modulators of amyloid aggregation |
| 06/05/2002 | EP0804182B1 Use of gabapentin in the treatment of anxiety and panic |
| 06/05/2002 | EP0799046B1 Stable solutions of 2-chloro-2'-deoxyadenosine |
| 06/05/2002 | EP0788501B1 Protein kinase inhibitors for treatment of neurological disorders |
| 06/05/2002 | EP0788361B1 Novel compositions based on a synergistic combination of one or more vrd ligands and retinoids |
| 06/05/2002 | EP0758241B1 Use of certain methanebisphosphonic acid derivatives to prevent prosthesis loosening and prosthesis migration |
| 06/05/2002 | EP0755386B1 Benzamide derivative, compositions containing said derivative and use thereof |
| 06/05/2002 | EP0754460B1 Antiinflammatory agents |
| 06/05/2002 | EP0752866B1 Medicaments for treating restenosis, comprising nitric oxide releasing polymers |
| 06/05/2002 | EP0752851B1 Process for preparing a pharmaceutical formulation |
| 06/05/2002 | EP0741574B1 Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
| 06/05/2002 | EP0722319B1 Anthracyclinone derivatives and their use in amyloidosis |
| 06/05/2002 | EP0711282B1 Compounds as pde iv and tnf inhibitors |
| 06/05/2002 | EP0684825B1 Kit for preventing or inhibiting fertilization |
| 06/05/2002 | EP0656791B1 Therapeutic compositions comprising pqq and a reducing agent |
| 06/05/2002 | EP0642516B1 Macrocyclic immunomodulators |
| 06/05/2002 | EP0632723B1 Use of transglutaminase inhibitor for the treatment of scar tissue |
| 06/05/2002 | EP0629199B1 Indole derivatives as 5-ht1 agonists |
| 06/05/2002 | EP0627914B1 Use of butylurea as contraceptive agent |
| 06/05/2002 | EP0612211B1 Alteration of rate and character of hair growth |
| 06/05/2002 | CN1352683A Compositions and methods for the treatment and diagnosis of breast cancer |
| 06/05/2002 | CN1352646A Camptothecin analogs and methods of preparation thereof |
| 06/05/2002 | CN1352644A I-amino triazolo [4,3-alpha] quinazoline -5-ones and/or -5-thiones inhibiting phosphodiesterase IV |
| 06/05/2002 | CN1352643A Novel method for producing doxazosin mesylate in a crystalline modification designated as form A |
| 06/05/2002 | CN1352642A Farnesyl protein transferase inhibitors |
| 06/05/2002 | CN1352641A Isonipecotamides for the treatment of integrin mediated disorders |
| 06/05/2002 | CN1352640A Mutual prodrugs of amlodipine and atorvastatin |
| 06/05/2002 | CN1352639A Novel tricyclic compounds and their use in medicine, process for their production and pharmaceutical composition containing them |
| 06/05/2002 | CN1352638A Novel polyhydroxypyrazine derivatives, preparation and pharmaceutical compositions containing same |
| 06/05/2002 | CN1352636A Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 06/05/2002 | CN1352635A Quinoline derivatives as inhibitors of MEK enzymes |
| 06/05/2002 | CN1352634A Process for preparing amlodipine benzenesulphonate |
| 06/05/2002 | CN1352632A N-substituted-N'-substituted urea derivative and use thereof as TNF-Alpha production inhibitor |
| 06/05/2002 | CN1352631A Aromatic amides |
| 06/05/2002 | CN1352571A Medicaments containing doxazosin-mesylate of crystalline modification D |
| 06/05/2002 | CN1352568A Water soluble compositions for bioactive lipophilic compounds |